| Home | E-Submission | Sitemap | Editorial Office |  
Update of the Diagnostic and Therapeutic Role of the Pelvic Lymph Node Dissection Boundaries During Radical Cystectomy in Muscle Invasive Bladder Cancer
Radical cystectomy (RC) is the gold standard treatment option for muscle invasive bladder cancer (MIBC). However, up to 25% of patients who undergo RC show metastatic lymph node deposits during the procedure. In such cases, the 5-year survival rate is reported to be 25%–30%. Pe...
Enhanced Recovery After Surgery Program for Radical Cystectomy
Even with advances in perioperative medical care, anesthetic management, and surgical techniques, radical cystectomy (RC) which remains the gold standard therapy for the treatment of muscle-invasive bladder cancer, yet is still associated with a high morbidity rate as well as a ...
Clinical Utility of Combining Prostate Health Index and PI-RADS Version 2 to Improve Detection of Clinically Significant Prostate Cancer
Purpose: To evaluate the performance of combining prostate health index (PHI) and Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) for detection of clinically significant prostate cancer (csPCa). Materials and Methods: We retrospectively reviewed patients who un...
Current Issue
Volume 20(2); May 2022
Volume 20(1); February 2022
Volume 19(4); November 2021
Volume 19(3); August 2021
Volume 19(2); May 2021
RSS feed
Review Articles
71 근육 침습 방광암에서 근치적 방광절제술 시 진단 및 치료적 역할에 있어 골반 림프절 절제술의 적절한 범위
권휘안, 서호경
Korean J Urol Oncol. 2022;20(2):71-81.   Published online May 26, 2022
DOI: https://doi.org/10.22465/kjuo.2022.20.2.71
82 방광암 환자에서 방광 내 치료의 현재와 미래
성신우, 신영재, 장인호, 김정훈
Korean J Urol Oncol. 2022;20(2):82-91.   Published online May 26, 2022
DOI: https://doi.org/10.22465/kjuo.2022.20.2.82
92 근치적 방광절제술 시 수술 후 조기 회복 프로토콜 Enhanced Recovery After Surgery
권휘안, 서호경
Korean J Urol Oncol. 2022;20(2):92-106.   Published online May 26, 2022
DOI: https://doi.org/10.22465/kjuo.2022.20.2.92
Original Articles
107 임상적으로 유의미한 전립선암의 예측 향상을 위한 Prostate Health Index와 PI-RADS Version 2 조합의 유용성
송 완, 이충언, 정재훈, 강민용, 성현환, 전황균, 정병창, 서성일, 전성수, 이현무
Korean J Urol Oncol. 2022;20(2):107-114.   Published online May 26, 2022
DOI: https://doi.org/10.22465/kjuo.2022.20.2.107
115 국내 전이성 투명세포 신장암 환자의 1차 표적치료제 동향: Sunitinib과 Pazopanib, 다기관 연구
최민수, 신택준, 김병훈, 김천일, 이경섭, 최석환, 김현태, 김태환, 권태균, 고영휘, 하윤수, 박재신, 권세윤
Korean J Urol Oncol. 2022;20(2):115-122.   Published online May 26, 2022
DOI: https://doi.org/10.22465/kjuo.2022.20.2.115
123 Prostate-Specific Antigen Variation as a Predictor of Prostate Cancer in Patients With Prostate-Specific Antigen ≤20 ng/mL Who Underwent Magnetic Resonance Imaging-Targeted Prostate Biopsy
Tae Hyun Hwang, Kwang Suk Lee, Kyo Chul Koo, Byung Ha Chung, Jeong Woo Yoo
Korean J Urol Oncol. 2022;20(2):123-132.   Published online May 26, 2022
DOI: https://doi.org/10.22465/kjuo.2022.20.2.123
Case Report
133 Peripheral T-Cell Lymphoma of Urinary Bladder Presenting With Just Irritative Voiding Symptoms
Byung Hoon Kim
Korean J Urol Oncol. 2022;20(2):133-137.   Published online May 26, 2022
DOI: https://doi.org/10.22465/kjuo.2022.20.2.133
Editorial Office
Department of Urology, Chung-Ang University Hospital
102 Heukseok-ro, Dongjak-gu, Seoul 06973, Korea
Tel: +82-2-6299-1819   Fax: +82-2-6294-1406   E-mail: journal@kjuo.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Urological Oncology Society and The Korean Prostate Society.                 Developed in M2PI
Close layer
prev next